Namibia's Eos Capital achieves first exit
Eos Capital, through its Allegrow Fund, has exited its investment in Erongo Medical Group.
** For the best experience, download the free Africa Private Equity News app Android | iOS **
Namibian private equity firm Eos Capital, through its Allegrow Fund, has exited its investment in Erongo Medical Group (EMG).
Allegrow’s investment in EMG was executed as part of Eos Capital’s strategy to gain exposure to defensive, high-impact sectors with a particular focus on healthcare infrastructure and specialised medical services.
This transaction represents Eos Capital’s first realised exit since inception.
Elzine Mushambi, the managing director of Eos Capital, said: “The successful exit of our investment in EMG is a direct result of our focused strategy and active stewardship. It demonstrates our commitment to identifying resilient assets, driving value creation, and, ultimately, returning capital to our investors. This exit is a testament to the quality of our portfolio, the execution capability of our team and a significant win for the Namibian private equity landscape.”
Want to know who is raising, investing, and exiting in Africa? Get Africa Private Equity News’ monthly Dealmaker’s Log – a database of reported investment deals, exits, and fundraising closes. Subscribe now